ARID1A and neuroblastoma: ARID1A recurrent mutations exhibit a broad tumor distribution, with particularly high prevalence in endometrioid and clear-cell ovarian cancers, gastric cancer, bladder cancer (9, 10) and neuroblastomas(~6%) (11, 12).